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OBJECTIVE—This study aimed to assess the correlation between abdominal subcutaneous
adipose tissue (SAT) and metabolic syndrome (MetS) in Korean adults after adjusting for the
effects of visceral adipose tissue (VAT).
RESEARCHDESIGNANDMETHODS—TheSAT/VATratio(SVR)wascalculatedusing
abdominal computed tomography in 2,655 subjects. We used regression analyses to assess
whether the SVR predicted MetS.
RESULTS—For both sexes, the prevalence of elevated triglycerides, reduced HDL, and ele-
vated fasting glucose signiﬁcantly decreased with increasing quintiles of SVR (P for trend ,
0.05).TheprevalenceandoddsratiosofMetS signiﬁcantlydecreasedastheSVRincreased(men:
odds ratio 0.5 [95% CI 0.3–0.7]; women: 0.2 [0.1–0.5] for comparisons of lowest vs. highest
quintile; P for trend , 0.05).
CONCLUSIONS—After adjustment for VAT, abdominal SAT was inversely correlated with
the occurrence of MetS.
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M
etabolic syndrome (MetS) is asso-
ciated with an increased risk of
diabetes and cardiovascular mor-
tality (1). Abdominal obesity, a key com-
ponent of MetS, is a risk factor for type 2
diabetes (2), cardiovascular disease, and
mortality (3).
Abdominalfatiscomposedofdistinct
anatomical components: subcutaneous
adipose tissue (SAT) and visceral adipose
tissue (VAT). VAT is strongly associated
with metabolic risk factors (4,5). How-
ever, some studies have suggested a
beneﬁcial role of abdominal SAT (6). A
recentanimalstudyshowedthattransplan-
tation of SAT into the visceral fat area may
decrease fat mass and induce beneﬁcial
changes in serum glucose and insulin sen-
sitivity in mice (7). We postulated that ab-
dominal SAT is inversely associated with
cardiometabolic risk factors and MetS.
RESEARCH DESIGN AND
METHODS—A cross-sectional obser-
vational study of 2,655 men and non-
pregnant women was conducted. Eligible
subjects were healthy individuals who
voluntarily received routine comprehen-
sive health check-ups, including com-
puted tomography (CT) scan analyses of
abdominal adipose tissue, from January
to December 2008 at the Seoul National
University Hospital Healthcare System
Gangnam Center. Data were collected
through a questionnaire, anthropometric
measurements, blood samples, and CT
scans. Subjects with diabetes, cancer, or
other chronic wasting diseases were ex-
cluded. The Seoul National University
Hospital Institutional Review Board ap-
proved this study.
Measurements of abdominal adipose
tissue and covariates
Detailed descriptions of the method used
for the measurement of abdominal adi-
pose tissue have been published previ-
ously(8).Inbrief,a5-mmthickumbilical
level abdominal section from 16-detector
row CT imaging of the abdomen was ob-
tained. The cross-sectional area (cm
2)o f
the abdominal fat was calculated using
Rapidia2.8CTsoftware(INFINITT,Seoul,
Korea). The VAT area was deﬁned as intra-
abdominal fat bound by parietal perito-
neum or transversalis fascia, and the SAT
area was calculated bysubtracting the VAT
area from the total adipose tissue area.
Because of the high colinearity be-
tween SAT and VAT, adjustments to the
regression model or stratiﬁcation of VAT
are insufﬁcient to control for the effects of
VAT on SAT. The ratio between SAT and
VAT(SAT/VATratio[SVR])wastherefore
calculated and used in the current study.
MetSwasdeﬁnedaccordingtothemodiﬁed
National Cholesterol Education Program
Adult Treatment Panel III (9) and Asia-
Paciﬁc abdominal obesity criterion (10).
Statistical analysis
Means with 95% CI and numbers of
participants (%) with metabolic risk fac-
tors were compared across the SVR quin-
tiles. We used multivariate logistic
regressions to evaluate the association
between MetS and SVR after adjusting
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BRIEF REPORTfor age, smoking, alcohol consumption,
BMI, menopausal status, and hormonal
replacement therapy (women only). Data
are expressed as odds ratio (OR) [95%
CI]; and P for trend. All analyses were
performed using STATA (version 10.0).
Signiﬁcance was deﬁned as P , 0.05.
RESULTS—Forty percent of men and
25% of women had elevated blood pres-
sure,31%ofmenand15%ofwomenhad
elevated fasting glucose, and 25% of men
and 14% of women had MetS. The mean
SAT and VAT areas were 139.8 cm
2 and
134.4 cm
2 in men and 173.1 cm
2 and
80.0 cm
2 in women, respectively. Addi-
tional characteristics are listed in Sup-
plementary Table 1A.
Among women, the prevalence of ele-
vatedfastingglucose,elevatedtriglycerides
(TGs), and reduced HDL cholesterol
(HDL-C) signiﬁcantly decreased as the
SVRquintile increased(26, 16, and37%
in quintile 1 vs. 5, 4, and 11% in quintile
5,respectively;allPforlineartrend,0.05)
Robustlineardecreasesintheseriskfactors
were also seen among men (Supplementary
Table 1B).
Multivariable-adjusted logistic
regressions with SVR and MetS
ORs of MetS signiﬁcantly decreased
across all 5 quintiles of the SVR after
adjusting for covariates in both men (OR
1.0forquintile1vs.0.5inquintile5;95%
CI0.3–0.7forquintile5;Pforlineartrend
, 0.01) and women (OR 1.0 for quintile
1 vs. 0.2 in quintile 5; 95% CI 0.1–0.5
for quintile 5; P for linear trend , 0.01)
(Table 1).
CONCLUSIONS—The purpose of
thisstudywastoassessthecross-sectional
correlation of abdominal SAT with MetS
in a Korean study population. We found
that as the SVR increased, MetS compo-
nents such as reduced HDL-C, elevated
TGs, and elevated fasting glucose de-
creased in both sexes. Furthermore, this
relationship was maintained even after
the adjustment for a variety of variables.
Small adipocytes in SAT play the role
of powerful buffers, uptaking circulating
free fatty acids and TGs in the postpran-
dial period. But if they lose their function
in adipogenesis or fat storage capacity in
SAT, fat begins to accumulate in tissues
not suited for lipid storage such as VAT.
Dysfunction of SAT and ectopic fat con-
tribute to insulin resistance (11). Peroxi-
some proliferator–activated receptor-g
(PPAR-g) agonists stimulate the differen-
tiation of adipocytes, resulting in in-
creased accumulation capacity in SAT
(12). The PPAR-g coactivator 1a mRNA
expression is signiﬁcantly higher in sub-
cutaneous fat than in omental fat (13).
This mechanism explained the ﬁnding
that treatment with thiazolidinedione im-
proves insulin sensitivity (6).
VAT and SAT differ in cytokine se-
cretion proﬁle such as leptin, adiponectin,
interleukin-6, interleukin-8, plasminogen
activator inhibitor 1, and angiotensin,
which may play some role in the develop-
ment of MetS (14,15).
Longitudinal associations of VAT/
SAT change with MetS, and with leptin
and/or adiponectin level should be the
focus of future studies.
There are some potential limitations
to the current study. Gluteofemoral SAT,
which may act as a confounding factor,
was not considered in the study. How-
ever, the current study included the anal-
ysisofalargedatasetofCT-measuredSAT
andVAT.Moreover,thestudypopulation
was generally healthy, which implies that
the results can be applied to the general
Korean population.
In summary, increased SAT is nega-
tively correlated with the prevalence of
MetS.Cumulatively,theseresultsindicate
that SAT may be considered a protective
fat deposit.
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